191 related articles for article (PubMed ID: 26792550)
1. High COX-2 expression is associated with increased angiogenesis, proliferation and tumoural inflammatory infiltrate in canine malignant mammary tumours: a multivariate survival study.
Carvalho MI; Pires I; Prada J; Raposo TP; Gregório H; Lobo L; Queiroga FL
Vet Comp Oncol; 2017 Jun; 15(2):619-631. PubMed ID: 26792550
[TBL] [Abstract][Full Text] [Related]
2. Different role of COX-2 and angiogenesis in canine inflammatory and non-inflammatory mammary cancer.
Clemente M; Sánchez-Archidona AR; Sardón D; Díez L; Martín-Ruiz A; Caceres S; Sassi F; Dolores Pérez-Alenza M; Illera JC; Dunner S; Peña L
Vet J; 2013 Aug; 197(2):427-32. PubMed ID: 23489848
[TBL] [Abstract][Full Text] [Related]
3. COX-2 over-expression correlates with VEGF and tumour angiogenesis in canine mammary cancer.
Queiroga FL; Pires I; Parente M; Gregório H; Lopes CS
Vet J; 2011 Jul; 189(1):77-82. PubMed ID: 20675158
[TBL] [Abstract][Full Text] [Related]
4. Tumour-associated macrophages are associated with vascular endothelial growth factor expression in canine mammary tumours.
Raposo TP; Pires I; Carvalho MI; Prada J; Argyle DJ; Queiroga FL
Vet Comp Oncol; 2015 Dec; 13(4):464-74. PubMed ID: 24119241
[TBL] [Abstract][Full Text] [Related]
5. High COX-2 expression in canine mast cell tumours is associated with proliferation, angiogenesis and decreased overall survival.
Gregório H; Raposo T; Queiroga FL; Pires I; Pena L; Prada J
Vet Comp Oncol; 2017 Dec; 15(4):1382-1392. PubMed ID: 28467670
[TBL] [Abstract][Full Text] [Related]
6. Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis.
Carvalho MI; Pires I; Prada J; Lobo L; Queiroga FL
Vet Pathol; 2016 Nov; 53(6):1138-1146. PubMed ID: 27162119
[TBL] [Abstract][Full Text] [Related]
7. Canine mammary carcinomas: influence of histological grade, vascular invasion, proliferation, microvessel density and VEGFR2 expression on lymph node status and survival time.
Diessler ME; Castellano MC; Portiansky EL; Burns S; Idiart JR
Vet Comp Oncol; 2017 Jun; 15(2):450-461. PubMed ID: 26833549
[TBL] [Abstract][Full Text] [Related]
8. Cox-2 expression in canine mammary carcinomas: correlation with angiogenesis and overall survival.
Lavalle GE; Bertagnolli AC; Tavares WL; Cassali GD
Vet Pathol; 2009 Nov; 46(6):1275-80. PubMed ID: 19605908
[TBL] [Abstract][Full Text] [Related]
9. Expression of iNOS, COX-2 and VEGF in canine mammary tumours and non-neoplastic mammary glands: Association with clinicopathological features and tumour grade.
Anadol E; Yar Saglam AS; Gultiken N; Karakas K; Alcigir E; Alkan H; Kanca H
Acta Vet Hung; 2017 Sep; 65(3):382-393. PubMed ID: 28956485
[TBL] [Abstract][Full Text] [Related]
10. Concurrent expression of cyclo-oxygenase-2 and epidermal growth factor receptor in canine malignant mammary tumours.
Guimarães MJ; Carvalho MI; Pires I; Prada J; Gil AG; Lopes C; Queiroga FL
J Comp Pathol; 2014 Jan; 150(1):27-34. PubMed ID: 24060154
[TBL] [Abstract][Full Text] [Related]
11. Investigating associations of cyclooxygenase-2 expression with angiogenesis, proliferation, macrophage and T-lymphocyte infiltration in canine melanocytic tumours.
Gregório H; Raposo TP; Queiroga FL; Prada J; Pires I
Melanoma Res; 2016 Aug; 26(4):338-47. PubMed ID: 27105172
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral CD3+ T-lymphocytes immunoexpression and its association with c-Kit, angiogenesis, and overall survival in malignant canine mammary tumors.
Carvalho MI; Pires I; Dias M; Prada J; Gregório H; Lobo L; Queiroga F
Anal Cell Pathol (Amst); 2015; 2015():920409. PubMed ID: 26346272
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral FoxP3 expression is associated with angiogenesis and prognosis in malignant canine mammary tumors.
Carvalho MI; Pires I; Prada J; Gregório H; Lobo L; Queiroga FL
Vet Immunol Immunopathol; 2016 Oct; 178():1-9. PubMed ID: 27496736
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of vascular endothelial growth factor in canine mammary tumours.
Santos AA; Oliveira JT; Lopes CC; Amorim IF; Vicente CM; Gärtner FR; Matos AJ
J Comp Pathol; 2010 Nov; 143(4):268-75. PubMed ID: 20570280
[TBL] [Abstract][Full Text] [Related]
15. The role of vascular endothelial growth factor and its receptor Flk-1/KDR in promoting tumour angiogenesis in feline and canine mammary carcinomas: a preliminary study of autocrine and paracrine loops.
Millanta F; Silvestri G; Vaselli C; Citi S; Pisani G; Lorenzi D; Poli A
Res Vet Sci; 2006 Dec; 81(3):350-7. PubMed ID: 16556453
[TBL] [Abstract][Full Text] [Related]
16. Expression of vascular endothelial growth factor in canine inflammatory and non-inflammatory mammary carcinoma.
Millanta F; Caneschi V; Ressel L; Citi S; Poli A
J Comp Pathol; 2010 Jan; 142(1):36-42. PubMed ID: 19632688
[TBL] [Abstract][Full Text] [Related]
17. The role of Cox-2 expression in the prognosis of dogs with malignant mammary tumours.
Queiroga FL; Pires I; Lobo L; Lopes CS
Res Vet Sci; 2010 Jun; 88(3):441-5. PubMed ID: 19939424
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 expression is associated with infiltration of inflammatory cells in oral and skin canine melanomas.
Silveira TL; Veloso ES; Gonçalves INN; Costa RF; Rodrigues MA; Cassali GD; Del Puerto HL; Pang LY; Argyle DJ; Ferreira E
Vet Comp Oncol; 2020 Dec; 18(4):727-738. PubMed ID: 32323423
[TBL] [Abstract][Full Text] [Related]
19. Expression of vascular endothelial growth factor receptor Flk-1 in canine mammary tumours.
Restucci B; Borzacchiello G; Maiolino P; Martano M; Paciello O; Papparella S
J Comp Pathol; 2004; 130(2-3):99-104. PubMed ID: 15003465
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of immunohistochemical markers and histological classification in malignant canine mammary tumours.
Pastor N; Ezquerra LJ; Santella M; Caballé NC; Tarazona R; Durán ME
Vet Comp Oncol; 2020 Dec; 18(4):753-762. PubMed ID: 32336005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
